About Us

#YoungCancer Campaign Team

The #YoungCancer campaign is a month-long effort to spread awareness about young adult and adolescent Lymphoma on behalf of the Lymphoma Research Foundation. The campaign team is made up of five public relations students at Brigham Young University: Isabella Hwang, Madeline Almeida, Mikayla Smith, Joshua Taylor, and Ellie Glade.

Y the Navy Blue Ribbon?

There are two different types of Lymphoma: Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma. The former’s ribbon color is violet and the latter’s is green. Because no existing color represents both types of lymphoma, the #YoungCancer campaign decided to create a new symbol.

Young adults at Brigham Young University proudly wear navy blue to showcase school pride. Our upside-down navy blue ribbon in the shape of a Y connects the lymphoma and BYU communities.

With that, the upside-down ribbon encourages a new perspective on cancer, specifically lymphoma. Research shows that young people don’t know that lymphoma affects young people and definitely don’t believe that it could ever happen to them.

Finally, blue is the color of the Paul Foundation, the founding sponsor of the Lymphoma Research Foundation (see more info below).

The Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted exclusively to funding lymphoma research and supporting the lymphoma community through evidence-based education, support services, and resources.

It has invested over 2.2 million dollars in Lymphoma research and has hosted more than 70 patient and professional educational programs. 

Lymphoma research began in 1975 and continues at a rapid pace: just in the past decade, the FDA has approved four new treatments for chronic lymphocytic leukemia, two drugs that help patients with Hodgkin Lymphoma, and the first gene therapy (CAR T cell therapy) for B-cell Lymphoma. Most recently in 2019, it approved the first chemotherapy-free treatment for patients with slow-growing forms of Non-Hodgkin Lymphoma.